-+ 0.00%
-+ 0.00%
-+ 0.00%

ULTRAGENYX PHARMACEUTICAL - NAVINTA LICENSED TO MARKET GENERIC DOJOLVI FROM JANUARY 1, 2033 - SEC FILING

Reuters·10/19/2026 13:06:43

Please log in to view news